vimarsana.com
Home
Live Updates
Neuraptive Therapeutics, Inc. Announces Achievement of Proof
Neuraptive Therapeutics, Inc. Announces Achievement of Proof
Neuraptive Therapeutics, Inc. Announces Achievement of Proof of Concept in The NEUROFUSE Study of NTX-001 for the Adjunct Treatment of Transected Peripheral Nerves
The NEUROFUSE Study is an ongoing 48-week Multicenter, Randomized, evaluator-blinded, Phase 2a study in upper extremity nerve transections comparing NTX-001…
Related Keywords
Michigan ,
United States ,
,
Neuraptive Therapeutics Inc ,
Evaluator Blinded Study ,
Treatment Emergent Adverse Events ,
Serious Adverse Events ,
Michigan Hand Questionnaire ,
Numeric Pain Rating Scale ,
Semmes Weinstein Monofilament Test ,
Patient Global Impression ,
Week Results ,
Total Score ,
Secondary Endpoints ,